Cited by 130Adrenal and Paraganglionic TumorsAdrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis

Open access
Pelsma, Iris C M, Fassnacht, Martin, Tsagarakis, Stylianos, Terzolo, Massimo, Tabarin, Antoine, Sahdev, Anju, Newell-Price, John, Marina, Ljiljana +4 more·2023·European Journal of Endocrinology

Abstract

OBJECTIVE: To assess (1) comorbidities associated with and (2) treatment strategies for patients with adrenal incidentalomas and mild autonomous cortisol secretion (MACS; > 1.8 µg/dL (>50 nmol/L) cortisol level cut-off following the 1 mg dexamethasone suppression test). DESIGN: Systematic review and meta-analysis. METHODS: Seven databases were searched up to July 14, 2022. Eligible studies were (randomized) trials, cohort studies, and cross-sectional studies assessing comorbidities potentially attributable to cortisol excess or mortality in patients with adrenal incidentaloma with or without MACS or the effects of conservative or surgical management of MACS. Random-effects meta-analysis was performed to estimate pooled proportions (with 95% CIs). RESULTS: In 30 cross-sectional and 16 cohort studies (n = 17 156 patients in total), patients with MACS had a higher prevalence of diabetes (relative risk [RR] 1.44 [1.23-1.69]), hypertension (RR = 1.24 [1.16-1.32]), and dyslipidemia (RR = 1.23 [1.13-1.34]). All-cause mortality (adjusted for confounders) in patients with MACS, assessed in 4 studies (n = 5921), was increased (hazard ratio [HR] = 1.54 [1.27-1.81]). Nine observational studies (n = 856) and 2 randomized trials (n = 107) suggest an improvement in glucometabolic control (RR = 7.99 [2.95-21.90]), hypertension (RR = 8.75 [3.99-19.18]), and dyslipidemia (RR = 3.24 [1.19-8.82]) following adrenalectomy. CONCLUSIONS: The present systematic review and meta-analysis highlight the relevance of MACS, since both cardiometabolic morbidities and mortality appeared to have increased in patients with MACS compared to patients with non-functioning incidentalomas. However, due to heterogeneous definitions, various outcomes, selective reporting, and missing data, the reported pooled estimates need to be interpreted with caution. The small number of patients in randomized trials prevents any strong conclusion on the causality between MACS and these comorbidities.

Integrity signals

Registry

Crossref · 10.1093/ejendo/lvad134

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Although overt physical features may be absent, the subtle hypercortisolism seen in MACS has been associated with adverse cardiovascular and metabolic outcomes, including hypertension, diabetes, dyslipidemia, weight gain, osteoporosis, increased frailty, and increased mortality.

    “Although overt physical features may be absent, the subtle hypercortisolism seen in MACS has been associated with adverse cardiovascular and metabolic outcomes, including hypertension, diabetes, dyslipidemia, weight gain, osteoporosis, increased frailty, and increased mortality (33, 34, 97-101).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pelsma, I. C. M., Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Marina, L., Lorenz, K., Bancos, I., Arlt, W., & Dekkers, O. M.
Affiliations
  • Leiden University Medical Center (NL)
  • University of Würzburg (DE)
  • Evangelismos Hospital (GR)
  • Ospedale San Luigi Gonzaga (IT)
  • Université de Bordeaux (FR)
  • St Bartholomew's Hospital (GB)
  • Royal Hallamshire Hospital (GB)
  • University of Belgrade (RS)
  • Martin Luther University Halle-Wittenberg (DE)
  • Mayo Clinic (US)
  • University of Birmingham (GB)
  • Aarhus University (DK)
Corresponding author
Pelsma, Iris C M
Venue
European Journal of Endocrinology
Published
2023-10
Volume
189
Issue
4
Pages
S88-S101
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W4387396814
Cited by
130
References
19
Citations by year
2026: 60 · 2025: 40 · 2024: 25 · 2023: 4
FWCI
8.35
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
European Society of Endocrinology
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
mild autonomous cortisol secretion, adrenal incidentaloma, comorbidities, diabetes mellitus, hypertension, dyslipidemia, all-cause mortality, adrenalectomy, cortisol excess, cardiometabolic risk, dexamethasone suppression test, conservative treatment, surgical management, treatment outcomes, Cushing's syndrome, Cushing's disease
MeSH terms
Adrenal Gland Neoplasms, Cross-Sectional Studies, Humans, Hydrocortisone, Hypertension, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review